Identification and comparison of intestinal microbial diversity in patients at different stages of hepatic cystic echinococcosis.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 08 2024
Historique:
received: 22 04 2024
accepted: 12 08 2024
medline: 15 8 2024
pubmed: 15 8 2024
entrez: 14 8 2024
Statut: epublish

Résumé

There is a significant focus on the role of the host microbiome in different outcomes of human parasitic diseases, including cystic echinococcosis (CE). This study was conducted to identify the intestinal microbiome of patients with CE at different stages of hydatid cyst compared to healthy individuals. Stool samples from CE patients as well as healthy individuals were collected. The samples were divided into three groups representing various stages of hepatic hydatid cyst: active (CE1 and CE2), transitional (CE3), and inactive (CE4 and CE5). One family member from each group was selected to serve as a control. The gut microbiome of patients with different stages of hydatid cysts was investigated using metagenomic next-generation amplicon sequencing of the V3-V4 region of the 16S rRNA gene. In this study, we identified 4862 Operational Taxonomic Units from three stages of hydatid cysts in CE patients and healthy individuals with a combined frequency of 2,955,291. The most abundant genera observed in all the subjects were Blautia, Agathobacter, Faecalibacterium, Bacteroides, Bifidobacterium, and Prevotella. The highest microbial frequency was related to inactive forms of CE, and the lowest frequency was observed in the group with active forms. However, the lowest OTU diversity was found in patients with inactive cysts compared with those with active and transitional cyst stages. The genus Agatobacter had the highest OTU frequency. Pseudomonas, Gemella, and Ligilactobacillus showed significant differences among the patients with different stages of hydatid cysts. Additionally, Anaerostipes and Candidatus showed significantly different reads in CE patients compared to healthy individuals. Our findings indicate that several bacterial genera can play a role in the fate of hydatid cysts in patients at different stages of the disease.

Identifiants

pubmed: 39143364
doi: 10.1038/s41598-024-70005-5
pii: 10.1038/s41598-024-70005-5
doi:

Substances chimiques

RNA, Ribosomal, 16S 0

Types de publication

Journal Article Comparative Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

18912

Subventions

Organisme : Kerman University of Medical Sciences
ID : 400000473

Informations de copyright

© 2024. The Author(s).

Références

Deplazes, P. et al. Global distribution of alveolar and cystic echinococcosis. Adv. Parasitol. 95, 315–493 (2017).
pubmed: 28131365 doi: 10.1016/bs.apar.2016.11.001
Battelli, G. Echinococcosis: Costs, losses and social consequences of a neglected zoonosis. Vet. Res. Commun. 33, 47–52 (2009).
pubmed: 19575305 doi: 10.1007/s11259-009-9247-y
Casulli, A., Siles-Lucas, M. & Tamarozzi, F. Echinococcus granulosus sensu lato. Trends Parasitol. 35, 663–664 (2019).
pubmed: 31182386 doi: 10.1016/j.pt.2019.05.006
Brunetti, E., Kern, P. & Vuitton, D. A. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop. 114, 1–16 (2010).
pubmed: 19931502 doi: 10.1016/j.actatropica.2009.11.001
Blum, H. E. The human microbiome. Adv. Med. Sci. 62, 414–420 (2017).
pubmed: 28711782 doi: 10.1016/j.advms.2017.04.005
Amon, P. & Sanderson, I. What is the microbiome?. Arch. Dis. Child. Educ. Pract. 102, 257–260 (2017).
doi: 10.1136/archdischild-2016-311643
Spor, A., Koren, O. & Ley, R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat. Rev. Microbiol. 9, 279–290 (2011).
pubmed: 21407244 doi: 10.1038/nrmicro2540
Consortium & H. M. P,. Structure, function and diversity of the healthy human microbiome. Nature 486, 207–214 (2012).
doi: 10.1038/nature11234
Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59–65 (2010).
pubmed: 20203603 pmcid: 3779803 doi: 10.1038/nature08821
Devillard, E. et al. Differences between human subjects in the composition of the faecal bacterial community and faecal metabolism of linoleic acid. Microbiology 155, 513–520 (2009).
pubmed: 19202099 doi: 10.1099/mic.0.023416-0
Cao, D. et al. Alterations in the Gut Microbiota of Tibetan patients with echinococcosis. Front. Microbiol. https://doi.org/10.3389/fmicb.2022.860909 (2022).
doi: 10.3389/fmicb.2022.860909 pubmed: 36938131 pmcid: 9815537
Wilson, B. C., Vatanen, T., Cutfield, W. S. & O’Sullivan, J. M. The super-donor phenomenon in fecal microbiota transplantation. Front. Cell. Infect. Microbiol. 9, 2 (2019).
pubmed: 30719428 pmcid: 6348388 doi: 10.3389/fcimb.2019.00002
Reynolds, L. A. et al. Commensal-pathogen interactions in the intestinal tract: Lactobacilli promote infection with, and are promoted by, helminth parasites. Gut Microbes 5, 522–532 (2014).
pubmed: 25144609 doi: 10.4161/gmic.32155
Fricke, W. F. et al. Type 2 immunity-dependent reduction of segmented filamentous bacteria in mice infected with the helminthic parasite Nippostrongylus brasiliensis. Microbiome 3, 1–12 (2015).
Zhou, C. et al. Comparison of intestinal flora between patients with chronic and advanced Schistosoma japonicum infection. Parasit. Vectors 15, 413 (2022).
pubmed: 36345042 pmcid: 9640844 doi: 10.1186/s13071-022-05539-6
Kim, J. Y. et al. Chinese liver fluke Clonorchis sinensis infection changes the gut microbiome and increases probiotic Lactobacillus in mice. Parasitol. Res. 118, 693–699 (2019).
pubmed: 30623233 doi: 10.1007/s00436-018-6179-x
Zhu, M. et al. Alterations in gut microbiota profiles of mice infected with Echinococcus granulosus sensu lato microbiota profiles of mice infected with E Granulosus Sl. Acta Parasitol. https://doi.org/10.1007/s11686-022-00613-6 (2022).
doi: 10.1007/s11686-022-00613-6 pubmed: 36048399 pmcid: 9705484
Bao, J. et al. Echinococcus granulosus infection results in an increase in Eisenbergiella and Parabacteroides genera in the gut of mice. Front. Microbiol. 9, 2890 (2018).
pubmed: 30555437 pmcid: 6281689 doi: 10.3389/fmicb.2018.02890
Rooney, J. et al. Parasitic helminths and the host microbiome–a missing ‘extracellular vesicle-sized’link?. Trends Parasitol. https://doi.org/10.1016/j.pt.2022.06.003 (2022).
doi: 10.1016/j.pt.2022.06.003 pubmed: 35820945
Plieskatt, J. L. et al. Infection with the carcinogenic liver fluke Opisthorchis viverrini modifies intestinal and biliary microbiome. FASEB J. 27, 4572 (2013).
pubmed: 23925654 pmcid: 3804743 doi: 10.1096/fj.13-232751
Ramírez, A. L. et al. Describing the intestinal microbiota of Holstein Fasciola-positive and-negative cattle from a hyperendemic area of fascioliasis in central Colombia. PLoS Negl. Trop. Dis. 15, e0009658 (2021).
pubmed: 34370722 pmcid: 8375995 doi: 10.1371/journal.pntd.0009658
Gong, D., Gong, X., Wang, L., Yu, X. & Dong, Q. Involvement of reduced microbial diversity in inflammatory bowel disease. Gastroenterol. Res. Pract. 2016, 1 (2016).
doi: 10.1155/2016/6951091
Schnabl, B. & Brenner, D. A. Interactions between the intestinal microbiome and liver diseases. Gastroenterology 146, 1513–1524 (2014).
pubmed: 24440671 doi: 10.1053/j.gastro.2014.01.020
Jeffery, I. B., Quigley, E. M. M., Öhman, L., Simrén, M. & O’Toole, P. W. The microbiota link to irritable bowel syndrome: An emerging story. Gut Microbes 3, 572–576 (2012).
pubmed: 22895081 pmcid: 3495796 doi: 10.4161/gmic.21772
Dubourg, G. et al. Culturomics and pyrosequencing evidence of the reduction in gut microbiota diversity in patients with broad-spectrum antibiotics. Int. J. Antimicrob. Agents 44, 117–124 (2014).
pubmed: 25063078 doi: 10.1016/j.ijantimicag.2014.04.020
Jakobsson, H. E. et al. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS ONE 5, e9836 (2010).
pubmed: 20352091 pmcid: 2844414 doi: 10.1371/journal.pone.0009836
Sonnenburg, E. D. et al. Diet-induced extinctions in the gut microbiota compound over generations. Nature 529, 212–215 (2016).
pubmed: 26762459 pmcid: 4850918 doi: 10.1038/nature16504
Zhang, H., Sparks, J. B., Karyala, S. V., Settlage, R. & Luo, X. M. Host adaptive immunity alters gut microbiota. ISME J. 9, 770–781 (2015).
pubmed: 25216087 doi: 10.1038/ismej.2014.165
Lim, M. Y. et al. The effect of heritability and host genetics on the gut microbiota and metabolic syndrome. Gut gutjnl-2015 https://doi.org/10.1136/gutjnl-2015-311326 (2016).
doi: 10.1136/gutjnl-2015-311326
Frank, D. N. et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. 104, 13780–13785 (2007).
pubmed: 17699621 pmcid: 1959459 doi: 10.1073/pnas.0706625104
Wei, Y. et al. Alterations of gut microbiome in autoimmune hepatitis. Gut 69, 569–577 (2020).
pubmed: 31201284 doi: 10.1136/gutjnl-2018-317836
Kostic, A. D. et al. The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe 17, 260–273 (2015).
pubmed: 25662751 pmcid: 4689191 doi: 10.1016/j.chom.2015.01.001
Wells, P. M. et al. Associations between gut microbiota and genetic risk for rheumatoid arthritis in the absence of disease: A cross-sectional study. Lancet Rheumatol. 2, e418–e427 (2020).
pubmed: 33345197 pmcid: 7729822 doi: 10.1016/S2665-9913(20)30064-3
Onal, E. M., Afsar, B., Covic, A., Vaziri, N. D. & Kanbay, M. Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease. Hypertens. Res. 42, 123–140 (2019).
pubmed: 30504819 doi: 10.1038/s41440-018-0144-z
Astbury, S. et al. Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis. Gut Microbes 11, 569–580 (2020).
pubmed: 31696774 doi: 10.1080/19490976.2019.1681861
Kriss, M., Hazleton, K. Z., Nusbacher, N. M., Martin, C. G. & Lozupone, C. A. Low diversity gut microbiota dysbiosis: Drivers, functional implications and recovery. Curr. Opin. Microbiol. 44, 34–40 (2018).
pubmed: 30036705 pmcid: 6435260 doi: 10.1016/j.mib.2018.07.003
Kedia, S. et al. Gut microbiome diversity in acute severe colitis is distinct from mild to moderate ulcerative colitis. J. Gastroenterol. Hepatol. 36, 731–739 (2021).
pubmed: 32870508 doi: 10.1111/jgh.15232
Zhao, T. et al. Gut microbiota and rheumatoid arthritis: From pathogenesis to novel therapeutic opportunities. Front. Immunol. 13, 1007165 (2022).
pubmed: 36159786 pmcid: 9499173 doi: 10.3389/fimmu.2022.1007165
Liu, Z. & Yin, B. Alterations in the gut microbial composition and diversity of tibetan sheep infected with echinococcus granulosus. Front. Vet. Sci. 8, 778789 (2022).
pubmed: 35097041 pmcid: 8792969 doi: 10.3389/fvets.2021.778789
Hua, X. et al. The gut microbiota and associated metabolites are altered in sleep disorder of children with autism spectrum disorders. Front. Psychiatry 11, 855 (2020).
pubmed: 32982808 pmcid: 7493623 doi: 10.3389/fpsyt.2020.00855
Macfarlane, G. T. & Macfarlane, S. Fermentation in the human large intestine: Its physiologic consequences and the potential contribution of prebiotics. J. Clin. Gastroenterol. 45, S120–S127 (2011).
pubmed: 21992950 doi: 10.1097/MCG.0b013e31822fecfe
Huang, K. et al. Gut microbiota and metabolites in atrial fibrillation patients and their changes after catheter ablation. Microbiol. Spectr. 10, e01077-e1121 (2022).
pubmed: 35384710 pmcid: 9045169 doi: 10.1128/spectrum.01077-21
Cui, Y. et al. Gut microbiota composition and functional prediction in recurrent spontaneous abortion. Res. sq. https://doi.org/10.2120/rs.3.rs-906730/v1 (2021).
doi: 10.2120/rs.3.rs-906730/v1 pubmed: 34013243 pmcid: 8132233
Schwiertz, A. et al. Anaerostipes caccae gen. nov., sp. nov., a new saccharolytic, acetate-utilising, butyrate-producing bacterium from human faeces. Syst. Appl. Microbiol. 25, 46–51 (2002).
pubmed: 12086188 doi: 10.1078/0723-2020-00096
Furusawa, Y. et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446–450 (2013).
pubmed: 24226770 doi: 10.1038/nature12721
Jonsson, H., Hugerth, L. W., Sundh, J., Lundin, E. & Andersson, A. F. Genome sequence of segmented filamentous bacteria present in the human intestine. Commun. Biol. 3, 485 (2020).
pubmed: 32887924 pmcid: 7474095 doi: 10.1038/s42003-020-01214-7
Shi, Z. et al. Segmented filamentous bacteria prevent and cure rotavirus infection. Cell 179, 644–658 (2019).
pubmed: 31607511 pmcid: 7525827 doi: 10.1016/j.cell.2019.09.028
Ajibola, O., Penumutchu, S., Gulumbe, B., Aminu, U. & Belenky, P. Longitudinal analysis of the impacts of urogenital schistosomiasis on the gut microbiota of adolescents in Nigeria. Res. Sq. 4, 35 (2023).
Chen, J. et al. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci. Rep. 6, 28484 (2016).
pubmed: 27346372 pmcid: 4921909 doi: 10.1038/srep28484
Radwan, S. et al. A comparative study of the gut microbiome in Egyptian patients with type I and type II diabetes. PLoS One 15, e0238764 (2020).
pubmed: 32903276 pmcid: 7480833 doi: 10.1371/journal.pone.0238764
Shahi, S. K., Freedman, S. N. & Mangalam, A. K. Gut microbiome in multiple sclerosis: The players involved and the roles they play. Gut Microbes 8, 607–615 (2017).
pubmed: 28696139 pmcid: 5730390 doi: 10.1080/19490976.2017.1349041
Rogan, M. T., Bodell, A. J. & Craig, P. S. Post-encystment/established immunity in cystic echinococcosis: Is it really that simple?. Parasite Immunol. 37, 1–9 (2015).
pubmed: 25283301 doi: 10.1111/pim.12149
Li, Z.-D. et al. Multiplex cytokine and antibody profile in cystic echinococcosis patients during a three-year follow-up in reference to the cyst stages. Parasit. Vectors 13, 1–10 (2020).
doi: 10.1186/s13071-020-4003-9
Pang, N. et al. TGF-β/Smad signaling pathway positively up-regulates the differentiation of Interleukin-9-producing CD4+ T cells in human Echinococcus granulosus infection. J. Infect. 76, 406–416 (2018).
pubmed: 29391143 doi: 10.1016/j.jinf.2018.01.005
Ahn, C.-S. et al. Alteration of immunoproteome profile of Echinococcus granulosus hydatid fluid with progression of cystic echinococcosis. Parasit. Vectors 8, 1–10 (2015).
doi: 10.1186/s13071-014-0610-7
Örsten, S. et al. Can parasite-derived microRNAs differentiate active and inactive cystic echinococcosis patients?. Parasitol. Res. 121, 191–196 (2022).
pubmed: 34811587 doi: 10.1007/s00436-021-07382-7
Kariyanna, P. T. et al. Risk factors and patient profile of infective endocarditis by Gemella spp. Am. J. Med. Case Rep. 9, 467–478 (2021).
doi: 10.12691/ajmcr-9-9-8
Loftus, M., Hassouneh, S.A.-D. & Yooseph, S. Bacterial community structure alterations within the colorectal cancer gut microbiome. BMC Microbiol. 21, 1–18 (2021).
doi: 10.1186/s12866-021-02153-x
Zheng, P., Li, Z. & Zhou, Z. Gut microbiome in type 1 diabetes: A comprehensive review. Diabetes. Metab. Res. Rev. 34, e3043 (2018).
pubmed: 29929213 pmcid: 6220847 doi: 10.1002/dmrr.3043
Ribeiro Sobrinho, A. P. et al. Cytokine production in response to endodontic infection in germ-free mice. Oral Microbiol. Immunol. 17, 344–353 (2002).
pubmed: 12485325 doi: 10.1034/j.1399-302X.2002.170603.x
Kishikawa, T. et al. A metagenome-wide association study of gut microbiome in patients with multiple sclerosis revealed novel disease pathology. Front. Cell. Infect. Microbiol. 10, 585973 (2020).
pubmed: 33363050 pmcid: 7759502 doi: 10.3389/fcimb.2020.585973
Derakhshani, A. et al. Natural history of Echinococcus granulosus microcyst development in long term in vitro culture and molecular and morphological changes induced by insulin and BMP-4. Front. Vet. Sci. 9, 1068602 (2023).
pubmed: 36699324 pmcid: 9868913 doi: 10.3389/fvets.2022.1068602
Amri, M., Mezioug, D., Ait-Aissa, S. & Touil-Boukoffa, C. In vivo IL-12 and IL-8 production in hydatic patients and their possible diffusion in hydatid cysts. Eur. Cytokine Netw. 19, 142–148 (2008).
pubmed: 18775805
Zawistowska-Rojek, A., Kośmider, A., Stępień, K. & Tyski, S. Adhesion and aggregation properties of Lactobacillaceae strains as protection ways against enteropathogenic bacteria. Arch. Microbiol. 204, 285 (2022).
pubmed: 35478049 pmcid: 9046290 doi: 10.1007/s00203-022-02889-8
Tohno, M. et al. A novel species of lactic acid bacteria, Ligilactobacillus pabuli sp. Nov., isolated from alfalfa silage. Int. J. Syst. Evol. Microbiol. 72, 5587 (2022).
doi: 10.1099/ijsem.0.005587
Zhao, Y. et al. Alterations of the mice gut microbiome via Schistosoma japonicum ova-induced granuloma. Front. Microbiol. 10, 352 (2019).
pubmed: 30891012 pmcid: 6411663 doi: 10.3389/fmicb.2019.00352
Peran, L. et al. Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis. World J. Gastroenterol. WJG. 11, 5185 (2005).
pubmed: 16127750
Yao, M. et al. Improved functionality of Ligilactobacillus salivarius Li01 in alleviating colonic inflammation by layer-by-layer microencapsulation. NPJ Biofilms Microbiomes. 7, 58 (2021).
pubmed: 34244520 pmcid: 8270932 doi: 10.1038/s41522-021-00228-1
Odamaki, T. et al. Age-related changes in gut microbiota composition from newborn to centenarian: A cross-sectional study. BMC Microbiol. 16, 1–12 (2016).
doi: 10.1186/s12866-016-0708-5
Jandhyala, S. M. et al. Role of the normal gut microbiota. World J. Gastroenterol. WJG 21, 8787 (2015).
pubmed: 26269668 doi: 10.3748/wjg.v21.i29.8787
Nagpal, R. et al. Ontogenesis of the gut microbiota composition in healthy, full-term, vaginally born and breast-fed infants over the first 3 years of life: A quantitative bird’s-eye view. Front. Microbiol. 8, 1388 (2017).
pubmed: 28785253 pmcid: 5519616 doi: 10.3389/fmicb.2017.01388
Yu, Y., Lee, C., Kim, J. & Hwang, S. Group-specific primer and probe sets to detect methanogenic communities using quantitative real-time polymerase chain reaction. Biotechnol. Bioeng. 89, 670–679 (2005).
pubmed: 15696537 doi: 10.1002/bit.20347
Mancini, M. V. et al. Estimating bacteria diversity in different organs of nine species of mosquito by next generation sequencing. BMC Microbiol. 18, 1–10 (2018).
doi: 10.1186/s12866-018-1266-9
Lai, Z. et al. The gut microbiota in liver transplantation recipients during the perioperative period. Front. Physiol. 13, 854017 (2022).
pubmed: 35530507 pmcid: 9075733 doi: 10.3389/fphys.2022.854017
Robeson, M. S. et al. RESCRIPt: Reproducible sequence taxonomy reference database management. PLoS Comput. Biol. 17, e1009581 (2021).
pubmed: 34748542 pmcid: 8601625 doi: 10.1371/journal.pcbi.1009581
Quast, C. et al. The SILVA ribosomal RNA gene database project: Improved data processing and web-based tools. Nucl. Acids Res. 41, D590–D596 (2012).
pubmed: 23193283 pmcid: 3531112 doi: 10.1093/nar/gks1219

Auteurs

Elham Akhlaghi (E)

Research Center for Hydatid Disease in Iran, Department of Medical Parasitology, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.

Elham Salari (E)

Department of Plant Protection, Faculty of Plant Production, Gorgan University of Agricultural Sciences and Natural Resources, Gorgan, Iran.

Mehdi Mansouri (M)

Department of Agricultural Biotechnology, Faculty of Agriculture, Shahid Bahonar University of Kerman, Kerman, Iran.

Mohammad Shafiei (M)

Research Center for Hydatid Disease in Iran, Department of Surgery, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.

Davood Kalantar-Neyestanaki (D)

Medical Mycology and Bacteriology Research Center, Kerman University of Medical Sciences, Kerman, Iran.
Department of Medical Microbiology, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.

Hossein Aghassi (H)

Research Center for Hydatid Disease in Iran, Department of Medical Parasitology, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.

Majid Fasihi Harandi (M)

Research Center for Hydatid Disease in Iran, Department of Medical Parasitology, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran. majid.fasihi@gmail.com.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH